Fig. 3: Neutralizing activity of AGP-R mAbs against MARV and RAVV. | npj Viruses

Fig. 3: Neutralizing activity of AGP-R mAbs against MARV and RAVV.

From: Discovery of potent cross-neutralizing antibodies against Marburg and Ravn viruses with therapeutic potential

Fig. 3

Neutralizing activities of mAbs against MARV (Angola strain) (a) and RAVV (b) were evaluated using plaque reduction neutralization tests. Relative infectivity was calculated by setting the infectivity value of the control in the absence of antibodies as 100%. Data represent the mean ± standard error of three independent experiments. Logistic curves were generated using nonlinear four-parameter regression analysis and are shown as solid lines; dashed lines represent 95% confidence intervals. The coefficient of determination (R2) values, indicating the goodness of fit, are shown in the graph.

Back to article page